Crossmark

Decrease in total protein level of Bruton’s tyrosine kinase during ibrutinib therapy in chronic lymphocytic leukemia lymphocytes

Published Online: 2016-05-20

Published Print: 2016-08

Authors

Cervantes-Gomez, F

Kumar Patel, V

Bose, P

Keating, M J

Gandhi, V
License Information

Text and Data Mining valid from 2016-05-20

Version of Record valid from 2016-05-20
More Information

Article History

First Online: 20 May 2016

Competing interests

: VG has a sponsored research agreement with Pharmacyclics, Inc. Other authors do not have any conflict of interest.

Document is current